生发泡卵母细胞拯救:无价值治疗还是以患者为中心的策略?八年临床经验
该回顾性研究分析了47例预后不良患者(MII≤6、成熟率<80%、GV≥4)的GV拯救经验,发现GV拯救使可用MII数增加75%,并带来20%的相对累积活产率提升。拯救来源的囊胚形态和整倍体率与对照相似,但囊胚形成率显著较低。
要点
- GV拯救使每患者可用MII数增加75%,并减少移植取消。
- 拯救来源囊胚的形态和整倍体率与对照相似,但囊胚形成率显著较低。
- GV拯救使整倍体囊胚患者数相对增加8%,活产患者数相对增加20%。
核心结论
- GV拯救可增加成熟卵母细胞、受精卵、囊胚和整倍体胚胎数,降低移植取消率,并使累积活产率相对增加20%。
研究设计与样本
- 对266个GV卵母细胞进行拯救,并分析可用时差视频中拯救GV卵母细胞与同胞对照MII卵母细胞的形态学和形态动力学参数。
主要发现
- 266个GV卵母细胞中53.7%成熟为MII,使每患者可用MII数增加75%。
- MII与拯救MII的受精率相当,但拯救MII的囊胚形成率显著较低。
- 拯救来源囊胚的形态和整倍体率与对照相似,并在11例患者中贡献至少1枚额外整倍体胚胎。
- GV拯救使整倍体囊胚患者数相对增加8%,活产患者数相对增加20%。
- 成功拯救的GV卵母细胞显著更大且GVBD更快;拯救MII显著小于同胞对照MII。
关键数值与推荐
- 纳入标准:MII≤6、成熟率<80%(相对扳机时≥14 mm卵泡)、GV≥4。
- 患者获益定义为从拯救MII获得至少1枚整倍体囊胚。
临床怎么用
- 对于预后不良且成熟卵母细胞产率意外低的PGT-A周期,可考虑GV拯救以增加可用胚胎数和累积成功率。
局限性
- 回顾性设计,单中心私人IVF中心,样本量小(严格入选标准所致)。
- 结果适用于经验丰富实验室中接受PGT-A且MII产率意外低的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does germinal vesicle (GV) rescue by IVM provide a meaningful clinical benefit in patients with unexpectedly low mature oocyte yield, and which patient profiles are most likely to benefit? SUMMARY ANSWER: Especially in patients with more GV oocytes obtained, GV rescue increased the number of mature oocytes, zygotes, blastocysts, and euploid embryos per cycle, reduced transfer cancellation, and contributed to a 20% relative increase in cumulative live birth rate. WHAT IS KNOWN ALREADY: Immature oocytes retrieved during controlled ovarian stimulation are traditionally discarded due to their reduced developmental competence. Previous studies suggest that GV rescue may increase usable oocytes, but its clinical value, especially within a Pre-implantation Genetic Testing for Aneuploidies (PGT-A) framework, remains unclear. STUDY DESIGN, SIZE, DURATION: This retrospective clinical study analysed 8 years of GV rescue experience in a single centre (January 2017-December 2024), including 47 women (<39 years) undergoing ICSI with PGT-A who displayed suboptimal mature oocyte recovery (Metaphase II oocytes (MII) ≤6, maturity rate <80% relative to ≥14 mm follicles at ovulation trigger, and ≥4 GV oocytes). A sub-analysis of available time-lapse videos of rescued GV oocytes and sibling control MII oocytes was conducted to outline morphometric and morphodynamic determinants of rescue and blastulation. PARTICIPANTS/MATERIALS, SETTING, METHODS: All retrieved MII oocytes underwent ICSI, whereas GV oocytes were cultured in time-lapse systems for additional 24 h; those rescued (rMII) were inseminated. Outcomes included fertilization, blastulation, morphological quality, euploidy rates, and clinical outcomes after vitrified-warmed euploid blastocyst transfer. Patients' benefit was defined as obtaining ≥1 euploid blastocyst from rMII. Morphometric features (relevant areas, diameters, perimeters) and morphodynamic parameters (timing of GV breakdown [GVBD], metaphase-I duration and first polar body (PB1) extrusion, second polar body (PB2) extrusion, pronuclei appearance, juxtaposition and fading, and cleavage) were annotated. MAIN RESULTS AND THE ROLE OF CHANCE: Among 266 GV oocytes, 53.7% matured to MII, increasing the available MII yield per patient by 75%. Fertilization rates were comparable between MII and rMII, while blastulation was significantly lower for rMII. Nevertheless, rMII-derived blastocysts showed similar morphology and euploidy to controls and contributed ≥1 additional euploid embryo in 11 patients. These patients exhibited higher total cumulus-oocyte complexes, GV count, and superior rMII fertilization and blastulation, although the demographics and basal parameters as well as the sibling control MII competence were comparable. GV rescue contributed to an 8% relative increase in the number of patients with euploid blastocysts and to a 20% relative increase in the number of patients with a live birth. Successfully rescued GV oocytes were substantially larger and underwent faster GVBD. rMII oocytes were significantly smaller than sibling control MII oocytes. Among the former, earlier pronuclear juxtaposition and shorter cleavage timings were associated with successful blastocyst development. LIMITATIONS, REASONS FOR CAUTION: The design is retrospective at a private IVF centre. The sample size is small, although this is the consequence of purposely strict inclusion criteria. Findings apply to patients with unexpectedly low MII yield undergoing PGT-A cycles in experienced laboratories. WIDER IMPLICATIONS OF THE FINDINGS: GV rescue represents a patient-centred strategy that can increase cumulative IVF success in cycles with limited mature oocyte yield. Further refining of patient selection criteria and standardizing this approach may enhance its clinical utility in future appraisals. The definition of artificial intelligence-powered pipelines to extract relevant morphometric/morphodynamic features to inform future predictive tools along with improvements in rescue protocols represent important upcoming innovations in this area of research. STUDY FUNDING: The study was partially supported by the ESHRE Research Grant 2024. DISCLOSURES: The authors declare no conflict of interest related with the content of this manuscript. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Cimadomo D, Escrich L, Alegre L, et al. Germinal vesicle oocytes' rescue: a worthless treatment or a patient-centred approach? Eight years of clinical experience in poor prognosis patients. Hum Reprod. 2026. PMID: 42442002. doi:10.1093/humrep/deag115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。